| Prostate-specific antigen and prostate cancer: prediction, detection and monitoring H Lilja, D Ulmert, AJ Vickers Nature Reviews Cancer 8 (4), 268-278, 2008 | 1159 | 2008 |
| Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study AJ Vickers, D Ulmert, DD Sjoberg, CJ Bennette, T Björk, A Gerdtsson, ... Bmj 346, 2013 | 388 | 2013 |
| Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study AJ Vickers, AM Cronin, T Björk, J Manjer, PM Nilsson, A Dahlin, A Bjartell, ... Bmj 341, 2010 | 293 | 2010 |
| Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy AE Marciscano, A Ghasemzadeh, TR Nirschl, D Theodros, CM Kochel, ... Clinical Cancer Research 24 (20), 5058-5071, 2018 | 269 | 2018 |
| Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years H Lilja, D Ulmert, T Björk, C Becker, AM Serio, JA Nilsson, ... Journal of clinical oncology 25 (4), 431-436, 2007 | 248 | 2007 |
| A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index D Ulmert, R Kaboteh, JJ Fox, C Savage, MJ Evans, H Lilja, ... European urology 62 (1), 78-84, 2012 | 225 | 2012 |
| Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50 H Lilja, AM Cronin, A Dahlin, J Manjer, PM Nilsson, JA Eastham, ... Cancer 117 (6), 1210-1219, 2011 | 212 | 2011 |
| Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study S Carlsson, M Assel, D Sjoberg, D Ulmert, J Hugosson, H Lilja, A Vickers Bmj 348, 2014 | 186 | 2014 |
| miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions Z Hagman, O Larne, A Edsjö, A Bjartell, RA Ehrnström, D Ulmert, H Lilja, ... International Journal of Cancer 127 (12), 2768-2776, 2010 | 184 | 2010 |
| Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle DLJ Thorek, D Ulmert, NFM Diop, ME Lupu, MG Doran, R Huang, ... Nature communications 5 (1), 3097, 2014 | 183 | 2014 |
| Kinase regulation of human MHC class I molecule expression on cancer cells EJ Brea, CY Oh, E Manchado, S Budhu, RS Gejman, G Mo, P Mondello, ... Cancer immunology research 4 (11), 936-947, 2016 | 177* | 2016 |
| REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer C Svensson, J Ceder, D Iglesias-Gato, YC Chuan, ST Pang, A Bjartell, ... Nucleic acids research 42 (2), 999-1015, 2013 | 169 | 2013 |
| Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen AJ Vickers, DD Sjoberg, D Ulmert, E Vertosick, MJ Roobol, I Thompson, ... BMC medicine 12, 1-7, 2014 | 149 | 2014 |
| Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study D Ulmert, AM Cronin, T Björk, MF O'Brien, PT Scardino, JA Eastham, ... BMC medicine 6, 1-8, 2008 | 133 | 2008 |
| Prospective study on metabolic factors and risk of prostate cancer C Häggström, T Stocks, D Ulmert, T Bjørge, H Ulmer, G Hallmans, ... Cancer 118 (24), 6199-6206, 2012 | 129 | 2012 |
| Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 … D Ulmert, AM Serio, MF O'Brien, C Becker, JA Eastham, PT Scardino, ... Journal of Clinical Oncology 26 (6), 835-841, 2008 | 123 | 2008 |
| A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening AJ Vickers, A Gupta, CJ Savage, K Pettersson, A Dahlin, A Bjartell, ... Cancer Epidemiology, Biomarkers & Prevention 20 (2), 255-261, 2011 | 115 | 2011 |
| Whole-body and microenvironmental localization of radium-223 in naive and mouse models of prostate cancer metastasis DS Abou, D Ulmert, M Doucet, RF Hobbs, RC Riddle, DLJ Thorek Journal of the National Cancer Institute 108 (5), djv380, 2016 | 109 | 2016 |
| Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication G Garcia, A Sharma, A Ramaiah, C Sen, A Purkayastha, DB Kohn, ... Cell reports 35 (1), 2021 | 102 | 2021 |
| Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen D Ulmert, MJ Evans, JP Holland, SL Rice, J Wongvipat, K Pettersson, ... Cancer discovery 2 (4), 320-327, 2012 | 84 | 2012 |
